HEADER HYDROLASE/HYDROLASE INHIBITOR 23-MAR-05 1Z71
TITLE THROMBIN AND P2 PYRIDINE N-OXIDE INHIBITOR COMPLEX STRUCTURE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: THROMBIN;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: ALPHA-THROMBIN;
COMPND 5 SYNONYM: COAGULATION FACTOR II;
COMPND 6 EC: 3.4.21.5;
COMPND 7 MOL_ID: 2;
COMPND 8 MOLECULE: HIRUDIN IIIB';
COMPND 9 CHAIN: B;
COMPND 10 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 MOL_ID: 2;
SOURCE 6 SYNTHETIC: YES;
SOURCE 7 ORGANISM_SCIENTIFIC: HIRUDO MEDICINALIS;
SOURCE 8 ORGANISM_TAXID: 6421;
SOURCE 9 OTHER_DETAILS: OCCURS NATURALLY IN MEDICINAL LEECH HIRUDO
SOURCE 10 MEDICINALIS
KEYWDS THROMBIN INHIBITOR COMPLEX, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR
KEYWDS 2 COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR P.G.NANTERMET,C.S.BURGEY,K.A.ROBINSON,J.M.PELLICORE,C.L.NEWTON,
AUTHOR 2 J.Z.DENG,T.A.LYLE,H.G.SELNICK,S.D.LEWIS,B.J.LUCAS,J.A.KRUEGER,
AUTHOR 3 C.MILLER-STEIN,R.B.WHITE,B.WONG,D.R.MCMASTERS,A.A.WALLACE,J.J.LYNCH
AUTHOR 4 JR.,Y.YAN,Z.CHEN,L.KUO,S.J.GARDELL,J.A.SHAFER,J.P.VACCA
REVDAT 6 16-OCT-24 1Z71 1 REMARK LINK
REVDAT 5 11-OCT-17 1Z71 1 REMARK
REVDAT 4 13-JUL-11 1Z71 1 VERSN
REVDAT 3 24-FEB-09 1Z71 1 VERSN
REVDAT 2 14-JUN-05 1Z71 1 JRNL
REVDAT 1 17-MAY-05 1Z71 0
JRNL AUTH P.G.NANTERMET,C.S.BURGEY,K.A.ROBINSON,J.M.PELLICORE,
JRNL AUTH 2 C.L.NEWTON,J.Z.DENG,H.G.SELNICK,S.D.LEWIS,B.J.LUCAS,
JRNL AUTH 3 J.A.KRUEGER,C.MILLER-STEIN,R.B.WHITE,B.WONG,D.R.MCMASTERS,
JRNL AUTH 4 A.A.WALLACE,J.J.LYNCH JR.,Y.YAN,Z.CHEN,L.KUO,S.J.GARDELL,
JRNL AUTH 5 J.A.SHAFER,J.P.VACCA,T.A.LYLE
JRNL TITL P(2) PYRIDINE N-OXIDE THROMBIN INHIBITORS: A NOVEL
JRNL TITL 2 PEPTIDOMIMETIC SCAFFOLD
JRNL REF BIOORG.MED.CHEM.LETT. V. 15 2771 2005
JRNL REFN ISSN 0960-894X
JRNL PMID 15911253
JRNL DOI 10.1016/J.BMCL.2005.03.110
REMARK 2
REMARK 2 RESOLUTION. 1.80 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : ENGH & HUBER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.0
REMARK 3 NUMBER OF REFLECTIONS : 31786
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : NULL
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.223
REMARK 3 FREE R VALUE : 0.254
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : 3173
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL
REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : NULL
REMARK 3 BIN FREE R VALUE : NULL
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2337
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 33
REMARK 3 SOLVENT ATOMS : 194
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.007
REMARK 3 BOND ANGLES (DEGREES) : 1.350
REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL
REMARK 3 IMPROPER ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : NULL
REMARK 3 KSOL : NULL
REMARK 3 BSOL : NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1Z71 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-APR-05.
REMARK 100 THE DEPOSITION ID IS D_1000032378.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 19-SEP-02
REMARK 200 TEMPERATURE (KELVIN) : 298
REMARK 200 PH : 7.3
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.54
REMARK 200 MONOCHROMATOR : YALE MIRRORS
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32360
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0
REMARK 200 DATA REDUNDANCY : 4.000
REMARK 200 R MERGE (I) : 0.04700
REMARK 200 R SYM (I) : 0.04700
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86
REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0
REMARK 200 DATA REDUNDANCY IN SHELL : 3.00
REMARK 200 R MERGE FOR SHELL (I) : 0.21900
REMARK 200 R SYM FOR SHELL (I) : 0.21900
REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.000
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: CNS
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 52.20
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.57
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PEG8K, SODIUM PHOSPHATE, PH 7.3, VAPOR
REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y,-Z
REMARK 290 3555 X+1/2,Y+1/2,Z
REMARK 290 4555 -X+1/2,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 34.98500
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.74500
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 34.98500
REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.74500
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 ASP A 14L
REMARK 465 GLY A 14M
REMARK 465 ARG A 15
REMARK 465 THR A 146A
REMARK 465 TRP A 146B
REMARK 465 THR A 146C
REMARK 465 ALA A 146D
REMARK 465 ASN A 146E
REMARK 465 VAL A 146F
REMARK 465 GLY A 146G
REMARK 465 LYS A 146H
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ILE A 14K CG1 CG2 CD1
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 PHE A 7 -86.55 -131.91
REMARK 500 TYR A 60A 84.12 -159.64
REMARK 500 ASN A 60G 73.73 -158.15
REMARK 500 HIS A 71 -59.40 -134.16
REMARK 500 ILE A 79 -57.79 -129.41
REMARK 500 GLU A 192 123.30 -37.71
REMARK 500 SER A 214 -77.42 -113.19
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L17 A 1001
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF HIRUDIN IIIB'
REMARK 999
REMARK 999 SEQUENCE
REMARK 999 ACCORDING TO AUTHORS, HIRUGEN WAS CHEMICALLY SYNTHESIZED.
DBREF 1Z71 A 1 246 UNP P00734 THRB_HUMAN 335 621
DBREF 1Z71 B 355 365 UNP P28511 ITHK_HIRME 55 65
SEQADV 1Z71 ALA B 365 UNP P28511 GLN 65 SEE REMARK 999
SEQRES 1 A 287 ASP CYS GLY LEU ARG PRO LEU PHE GLU LYS LYS SER LEU
SEQRES 2 A 287 GLU ASP LYS THR GLU ARG GLU LEU LEU GLU SER TYR ILE
SEQRES 3 A 287 ASP GLY ARG ILE VAL GLU GLY SER ASP ALA GLU ILE GLY
SEQRES 4 A 287 MET SER PRO TRP GLN VAL MET LEU PHE ARG LYS SER PRO
SEQRES 5 A 287 GLN GLU LEU LEU CYS GLY ALA SER LEU ILE SER ASP ARG
SEQRES 6 A 287 TRP VAL LEU THR ALA ALA HIS CYS LEU LEU TYR PRO PRO
SEQRES 7 A 287 TRP ASP LYS ASN PHE THR GLU ASN ASP LEU LEU VAL ARG
SEQRES 8 A 287 ILE GLY LYS HIS SER ARG THR ARG TYR GLU ARG ASN ILE
SEQRES 9 A 287 GLU LYS ILE SER MET LEU GLU LYS ILE TYR ILE HIS PRO
SEQRES 10 A 287 ARG TYR ASN TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA
SEQRES 11 A 287 LEU MET LYS LEU LYS LYS PRO VAL ALA PHE SER ASP TYR
SEQRES 12 A 287 ILE HIS PRO VAL CYS LEU PRO ASP ARG GLU THR ALA ALA
SEQRES 13 A 287 SER LEU LEU GLN ALA GLY TYR LYS GLY ARG VAL THR GLY
SEQRES 14 A 287 TRP GLY ASN LEU LYS GLU THR TRP THR ALA ASN VAL GLY
SEQRES 15 A 287 LYS GLY GLN PRO SER VAL LEU GLN VAL VAL ASN LEU PRO
SEQRES 16 A 287 ILE VAL GLU ARG PRO VAL CYS LYS ASP SER THR ARG ILE
SEQRES 17 A 287 ARG ILE THR ASP ASN MET PHE CYS ALA GLY TYR LYS PRO
SEQRES 18 A 287 ASP GLU GLY LYS ARG GLY ASP ALA CYS GLU GLY ASP SER
SEQRES 19 A 287 GLY GLY PRO PHE VAL MET LYS SER PRO PHE ASN ASN ARG
SEQRES 20 A 287 TRP TYR GLN MET GLY ILE VAL SER TRP GLY GLU GLY CYS
SEQRES 21 A 287 ASP ARG ASP GLY LYS TYR GLY PHE TYR THR HIS VAL PHE
SEQRES 22 A 287 ARG LEU LYS LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE
SEQRES 23 A 287 GLY
SEQRES 1 B 11 ASP PHE GLU GLU ILE PRO GLU GLU TYS LEU ALA
MODRES 1Z71 TYS B 363 TYR O-SULFO-L-TYROSINE
HET TYS B 363 16
HET L17 A1001 33
HETNAM TYS O-SULFO-L-TYROSINE
HETNAM L17 L17
HETSYN L17 2-(3-CHLORO-6-{[2,2-DIFLUORO-2-(1-OXIDOPYRIDIN-2-YL)
HETSYN 2 L17 ETHYL]AMINO}-1-OXIDOPYRIDIN-2-YL)-N-[1-(3-
HETSYN 3 L17 CHLOROPHENYL)ETHYL]ACETAMIDE
FORMUL 2 TYS C9 H11 N O6 S
FORMUL 3 L17 C22 H20 CL2 F2 N4 O3
FORMUL 4 HOH *194(H2 O)
HELIX 1 1 PHE A 7 SER A 11 5 5
HELIX 2 2 THR A 14B TYR A 14J 1 9
HELIX 3 3 ALA A 55 CYS A 58 5 4
HELIX 4 4 PRO A 60B ASP A 60E 5 4
HELIX 5 5 THR A 60I ASN A 62 5 3
HELIX 6 6 ASP A 125 LEU A 130 1 9
HELIX 7 7 GLU A 164 SER A 171 1 8
HELIX 8 8 LYS A 185 GLY A 186C 5 5
HELIX 9 9 LEU A 234 GLY A 246 1 13
HELIX 10 10 PRO B 360 ALA B 365 1 6
SHEET 1 A 7 SER A 20 ASP A 21 0
SHEET 2 A 7 GLN A 156 PRO A 161 -1 O VAL A 157 N SER A 20
SHEET 3 A 7 LYS A 135 GLY A 140 -1 N GLY A 136 O LEU A 160
SHEET 4 A 7 PRO A 198 LYS A 202 -1 O VAL A 200 N ARG A 137
SHEET 5 A 7 TRP A 207 TRP A 215 -1 O TYR A 208 N MET A 201
SHEET 6 A 7 GLY A 226 HIS A 230 -1 O PHE A 227 N TRP A 215
SHEET 7 A 7 MET A 180 ALA A 183 -1 N PHE A 181 O TYR A 228
SHEET 1 B 7 GLN A 30 ARG A 35 0
SHEET 2 B 7 GLU A 39 LEU A 46 -1 O CYS A 42 N LEU A 33
SHEET 3 B 7 TRP A 51 THR A 54 -1 O LEU A 53 N SER A 45
SHEET 4 B 7 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54
SHEET 5 B 7 LYS A 81 ILE A 90 -1 N GLU A 86 O LYS A 107
SHEET 6 B 7 LEU A 64 ILE A 68 -1 N VAL A 66 O SER A 83
SHEET 7 B 7 GLN A 30 ARG A 35 -1 N PHE A 34 O LEU A 65
SHEET 1 C 2 LEU A 60 TYR A 60A 0
SHEET 2 C 2 LYS A 60F ASN A 60G-1 O LYS A 60F N TYR A 60A
SSBOND 1 CYS A 1 CYS A 122 1555 1555 2.04
SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.04
SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.04
SSBOND 4 CYS A 191 CYS A 220 1555 1555 2.04
LINK C GLU B 362 N TYS B 363 1555 1555 1.33
LINK C TYS B 363 N LEU B 364 1555 1555 1.33
CISPEP 1 SER A 36A PRO A 37 0 0.03
SITE 1 AC1 19 HIS A 57 TYR A 60A TRP A 60D GLU A 97A
SITE 2 AC1 19 ASN A 98 ILE A 174 ASP A 189 ALA A 190
SITE 3 AC1 19 CYS A 191 SER A 195 VAL A 213 SER A 214
SITE 4 AC1 19 TRP A 215 GLY A 216 GLU A 217 GLY A 219
SITE 5 AC1 19 GLY A 226 PHE A 227 HOH A1051
SITE 1 AC2 17 PHE A 34 GLU A 39 LEU A 40 LEU A 65
SITE 2 AC2 17 ARG A 73 THR A 74 ARG A 75 TYR A 76
SITE 3 AC2 17 GLU A 80 LYS A 81 ILE A 82 HOH A1060
SITE 4 AC2 17 HOH A1135 HOH A1175 HOH B 120 HOH B 130
SITE 5 AC2 17 HOH B 140
CRYST1 69.970 71.490 72.260 90.00 100.50 90.00 C 1 2 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.014292 0.000000 0.002649 0.00000
SCALE2 0.000000 0.013988 0.000000 0.00000
SCALE3 0.000000 0.000000 0.014075 0.00000